Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis (clinicaltrials.gov) - Oct 15, 2026 - P2 | N=30 | Active, not recruiting | Sponsor: Hospital for Special Surgery, New York | Recruiting ➔ Active, not recruiting | Trial completion date: Jun 2026 ➔ Dec 2027 | Trial primary completion date: Jun 2026 ➔ Aug 2027
Enrollment closed • Trial completion date • Trial primary completion date • Immunology • Scleroderma • Systemic Sclerosis
|